Physician
Pediatric Hematology & Oncology
Dr. Darryl C. Longee, MD
|
|
Give Review
Doctor Darryl C. Longee, MD is an expert in the field of Pediatric Hematology & Oncology. He studied medicine at University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83 in research and 35 in primary care medicine Dr. Darryl C. Longee is also a published physician. He has 20 publication published. The most recent publication is: Metastatic rhabdomyosarcoma presenting as intracranial hemorrhage: imaging findings.
Publications
- Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas.
- Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme. Writing Committee for The Brain Tumor Center at Duke.
- Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
- Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis.
- Malignant supratentorial ganglioglioma (ganglion cell-giant cell glioblastoma): a case report and review of the literature.
- Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature.
- Metastatic rhabdomyosarcoma presenting as intracranial hemorrhage: imaging findings.
- Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas.
- High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
- Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
- Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections.
- Transient late magnetic resonance imaging changes suggesting progression of brain stem glioma: implications for entry criteria for phase II trials.
- Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
- Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine.
- Osteoblastic metastases from astrocytomas: a report of two cases.
- Molecular cytogenetic analysis of a medulloblastoma with isochromosome 17 and double minutes.
- Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
- Cytogenetic findings in a case of pediatric glioblastoma.
- Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome.
Schools
University of Arkansas For Medical Sciences
University Of Arkansas Children Hospital
Conditions Treated
- Anemia
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Duke University Hospital -
University of Arkansas for Medical Sciences -
University of Arkansas for Medical Sciences College of Medicine
Hospital
-
Duke University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Allen R. Potter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary M. Pelszynski, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gerardo Quezada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Della L. Howell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terry E. Pick, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Veronica H. Jude, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sven T. Berg, MD
This Doctor is OpenDoctor Recommended.
|